These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 13195551)

  • 1. [Biological activity of bone marrow in untreated acute leukemias; proliferation of leukemic cells].
    SACCHETTI C; BIANCHINI E
    Sang; 1954; 25(5):499-505. PubMed ID: 13195551
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abscence of chromosomes abnormalities and acute leukemia : relationships with normal bone marrow cells].
    Berger R; Bernheim A; Flandrin G
    C R Seances Acad Sci D; 1980 Jun; 290(24):1557-9. PubMed ID: 6773689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The parameters of cellular proliferation in acute (immature-cell) leukemias.
    Urasiński I; Kordecki H
    Pol Med Sci Hist Bull (1973); 1976; 15(3):305-10. PubMed ID: 995767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
    Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
    Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the protooncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remission.
    Preisler HD; Kinniburgh AJ; Wei-Dong G; Khan S
    Cancer Res; 1987 Feb; 47(3):874-80. PubMed ID: 2433029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nucleolar organizer activity of normal and leukemic cells in human bone marrow].
    Mamaev NN; Mamaeva SE; Liburkina IL; Kozlova TV; Medvedeva NV
    Tsitologiia; 1984 Jan; 26(1):46-51. PubMed ID: 6583880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
    Teichmann JV; Ludwig WD; Thiel E
    Nat Immun; 1992; 11(3):117-32. PubMed ID: 1392400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemic cell colony formation in soft agar by bone marrow cells and peripheral blood cells from untreated acute leukemia patients.
    Dicke KA; Tindle SE; Davis FM; Jagannath S; Tucker S; Lilien M; van Leeuwen P; Verma DS; Vellekoop L
    Exp Hematol; 1983 Apr; 11(4):341-50. PubMed ID: 6341080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro study of bone marrow from leukemia patients and patients without hematologic disease].
    Varga G; Borbényi Z; Krizsa F; Cserháti I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):125-33. PubMed ID: 2581857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of humoral regulators on proliferation and maturation of normal and leukemic cells.
    Karp JE; Burke PJ
    Cancer Res; 1976 May; 36(5):1674-9. PubMed ID: 1063598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro colony formation of transplantable rat leukemias in comparison with human acute myeloid leukemia.
    van Bekkum DW; van Oosterom P; Dicke KA
    Cancer Res; 1976 Mar; 36(3):941-6. PubMed ID: 1062232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human bone marrow fibroblastic cells can inhibit clonogenic growth of K562 cells.
    Noguchi K; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1985 Oct; 10(5):537-43. PubMed ID: 3870061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome aberrations and transforming genes in leukemic and non-leukemic patients with a history of atomic bomb exposure.
    Kamada N; Tanaka K; Kasegawa A
    Princess Takamatsu Symp; 1987; 18():125-34. PubMed ID: 3509830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
    Verdonck LF; Witteveen EO; van Heugten HG; Rozemuller E; Rijksen G
    Cancer Res; 1990 Jul; 50(13):4020-5. PubMed ID: 2354451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
    Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
    Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro growth characteristics of virally transformed murine myeloid cells.
    Nooter K; Bentvelzen P
    Cancer Res; 1976 Apr; 36(4):1246-50. PubMed ID: 177204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of lymphoid leukemia colony-forming cells in Abelson virus infected mice: differences in inbred strains.
    Earl CD; Scher CD
    J Cell Physiol; 1980 Aug; 104(2):153-62. PubMed ID: 7410487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow fibroblasts-conditioned medium regulates the proliferation of leukemic cells.
    Kubota T; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1988 Feb; 13(1):45-51. PubMed ID: 3232161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro growth of human myeloid leukemia bone marrow cells in liquid culture.
    Ciani A; Vanin V; Maiolo AT; Polli EE
    Isr J Med Sci; 1978 Dec; 14(12):1231-5. PubMed ID: 285047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells.
    Greenwood MF; Coleman MS; Hutton JJ; Lampkin B; Krill C; Bolium FJ; Holland P
    J Clin Invest; 1977 May; 59(5):889-99. PubMed ID: 265945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.